We have examined the expression and regulation of the two estrogen receptor (ER␣ and ER␤) genes in the rat ovary, using Northern blotting, RT-PCR, and in situ hybridization histochemistry. Northern blotting results show that the ovary expresses both ER␣ and ER␤ genes as single (ϳ6.5-kb) and multiple (ranging from ϳ1.0-kb to ϳ10.0-kb) transcripts, respectively. ER␣ mRNA is expressed at a level lower than ER␤ mRNA in immature rat ovaries. This relationship appears unchanged between sexually mature adult rats and immature rats. In sexually mature adult rats undergoing endogenous hormonal changes, whole ovarian content of ER␤ mRNA, as determined by RT-PCR, remained more or less constant with the exception of the evening of proestrus when ER␤ mRNA levels were decreased. Examination of ER␤ mRNA expression at the cellular level, by in situ hybridization, showed that ER␤ mRNA is expressed preferentially in granulosa cells of small, growing, and preovulatory follicles, although weak expression of ER␤ mRNA was observed in a subset of corpora lutea, and that the decrease in ER␤ mRNA during proestrous evening is attributable, at least in part, to downregulation of ER␤ mRNA in the preovulatory follicles. This type of expression and regulation was not typical for ER␣ mRNA in the ovary. Although whole ovarian content of ER␣ mRNA was clearly detected by RT-PCR, no apparent modulation of ER␣ mRNA levels was observed during the estrous cycle. Examination of ER␣ mRNA expression at the cellular level, by in situ hybridization, showed that ER␣ mRNA is expressed at a low level throughout the ovary with no particular cellular localization.
INTRODUCTION
Estrogen critically affects the growth and development of ovarian follicles during the female reproductive cycle (reviewed in Refs. 1-6) by stimulating the prolifer-ation of granulosa cells from small follicles (7) , increasing granulosa cell gonadotropin receptor levels and thus responsiveness of granulosa cells to gonadotropins (8, 9) , modulating progesterone production by granulosa cells (10) and androgen production by theca cells (11) , enhancing gap junction formation among granulosa cells (12) , and modulating luteal steroidogenic capacity (reviewed in Ref. 13 ). These intraovarian actions of estrogen indicate the presence of specific receptor molecules interacting with this steroid in the ovary. Indeed, the ovaries of a number of species have been shown to express estrogen-binding molecule(s) as determined by specific retention of radiolabeled estrogen (14, 15) , and specific binding capacity of estrogen in ovarian extracts (16) (17) (18) (19) . These binding studies suggest that ovarian estrogen receptor (ER)-like molecules exert steroid specificity and binding affinity similar to those of the well characterized conventional ER (20) , recently renamed ER␣ (21) . ER␣ is believed to mediate many of estrogen's actions in a variety of reproductive tissues, including the uterus (22, 23) . If the same scenario is applied to the ovary, ER␣ protein should be present at a detectable level in the ovary and elimination of the ER␣ gene in vivo should disrupt all ovarian functions requiring estrogen action, such as folliculogenesis. Although ER immunoreactivity has been found in ovaries of a limited number of species, such as the baboon and human (24) (25) (26) , disruption of the ER␣-gene in vivo did not eliminate the ability of small follicles to grow as evident from the presence of secondary and antral follicles in ER␣-knockout mice (27, 28) , arguing for the possibility that intraovarian action of estrogen may be mediated by molecular mechanisms requiring estrogen-binding molecules other than ER␣. This possibility is further supported by experimental results from our laboratory (29, 30) and others (31, 32) demonstrating that in the ovary, in contrast to the uterus, estrogen does not stimulate one of the best known genes targeted by ER, the progesterone receptor (PR) gene. In light of these observations, the identification of a second subtype of ER (ER␤) that is expressed in the ovary (21) may provide a fundamental understanding of the longstanding critical role of estrogen in ovarian function. This receptor has been shown to bind to estrogen with high affinity and steroid specificity very similar to that of the ER␣ (Ref. 21 and G.G.J.M. Kuiper, unpublished data). Thus, we sought to examine the expression and hormonal regulation of these two ERs (ER␣ and ER␤) in the rat ovary. We have used ovaries of immature rats treated with gonadotropins to stimulate folliculogenesis, ovulation, and luteinization, as well as of sexually mature rats during the estrous cycle. Our results demonstrate that 1) the primary ER subtype in the ovary is ER␤, although the ovary expresses both ER␣ and ER␤ genes, 2) ovarian expression of ER␤ mRNA is decreased during follicular development and differentiation, and 3) activation of LH/CG receptors down-regulates ER␤ mRNA expression in cultured rat granulosa cells.
RESULTS

Differential Expression of ER␣ and ER␤ mRNA Species in the Rat Ovary
To determine whether the two ERs (ER␣ and ER␤) are expressed at a comparable level in the rat ovary, we performed Northern analysis (Fig. 1A) and RT-PCR (Fig. 1, B and C) to specifically detect ER␣ and ER␤ transcripts in rat ovarian RNA. An equal amount of rat uterine RNA was used as a positive control since it expresses ER␣ mRNA at a high level. Forty micrograms of total RNA were fractionated on a 1% denaturing gel that was transferred onto a nylon membrane and probed for ER␣ using the hormone-binding domain of the rat ER␣ (20) or for ER␤ using the EcoRI/ PstI fragment (ϳ750 bp most 5Ј-end) of the rat ER␤ (21) . The results of Northern analyses performed under stringent conditions show that the ovary contains an ER␣ transcript (ϳ6.5 kb), as the uterus does, but at an extremely low level (Fig. 1A, left panel) . When the same blot was reprobed for ER␤ mRNA, the ovarian RNA was found to contain multiple transcripts of the ER␤ gene (ranging from ϳ1.0 kb to ϳ10.0 kb) at a detectable level whereas little ER␤ mRNA signal was detected in uterine RNA (Fig. 1A, middle panel) . These multiple ER␤ transcripts were better shown in RNA of isolated granulosa cells as compared with whole ovaries (Fig. 1A, right panel) , indicating that ER␤ mRNA is enriched in granulosa cells. Similar quantification results were obtained using RT-PCR assays performed under conditions generating a linear range of specific amplification of ER␣ and ER␤ mRNAs. A typical example of the relationship between cycle numbers and RT-PCR amplification of ER␣ and ER␤ mRNAs from a fixed concentration of ovarian RNA (1/4 of cDNA generated from 5 g RNA) is shown in Fig. 1B . This concentration of cDNA is within a linear range of amplification of ER␣ and ER␤ mRNAs (data not shown). Linear amplification of ER␣ and ER␤ mRNAs in ovarian samples was obtained using up to 30 cycles of PCR and thus, subsequent experiments were performed using 25 cycles of amplification. ER␣ and ER␤ RT-PCR products from the same ovarian or uterine cDNA samples show that the uterus predominantly expresses ER␣ mRNA while ER␤ is the predominant ER subtype expressed in the ovary (Fig. 1C) . These reactions amplified specific ER␣ and ER␤ PCR products of the expected size based upon our results using ER␣ [the human ER␣ (33)] or ER␤ [the rat ER␤ (21)] cDNA plasmids as controls.
ER␣ and ER␤ mRNA Expression in Rat Ovaries in Vivo
To gain insights into whether ovarian expression of the ER␣ or ER␤ gene is temporally associated with particular stages of the female reproductive cycle, we examined ER␣ and ER␤ mRNA levels in ovaries of 1) sexually mature adult rats throughout the reproductive cycle and 2) immature rats treated with exogenous gonadotropin combination (PMSG plus human CG), by performing RT-PCR and in situ hybridization. After 25 cycles of amplification at 66 C annealing temperature, ER␤ as well as ER␣ RT-PCR products were detectable in ovaries at all stages of the reproductive cycle (Fig. 2) . Again, ER␤ mRNA levels were higher than ER␣ mRNA levels in these samples. This is consistent with our observations showing a preferential amplification of ER␤ mRNA during coamplification of ER␣ and ER␤ mRNAs in the same samples (data not shown). ER␣ RT-PCR fragment was detected in all stages of the estrous cycle with less variation than that observed for ER␤. Quantification of ER␤ mRNA levels shows little variation during the cycle with the exception of the evening of proestrus when ER␤ mRNA levels were decreased. This decrease in ER␤ mRNA levels occurred after the onset of the preovulatory LH surge (our LH RIA results show that the preovulatory LH surge was initiated at 1600 h and peaked at 1800 h of proestrus in these animals, data not shown). Our results employing in situ hybridization followed by liquid emulsion autoradiography show that ER␣ mRNA is expressed at a low level with no particular cellular localization within the ovary, and that ER␤ mRNA in small and growing follicles remained more or less similar throughout the estrous cycle (data not shown), whereas ER␤ and LH receptor (LH-R) transcripts are coexpressed in preovulatory follicles of cycling rats and are down-regulated during the transition from proestrus to estrus (Fig. 3A) . Before the peak of the preovulatory LH surge (shown are 1400 h and 1800 h), preovulatory follicles express both ER␤ and LH-R mRNA in the granulosa cell layer. After the peak of the preovulatory LH surge, levels of both ER␤ and LH-R mRNA are substantially decreased (shown are 2200 h and 2400 h). An example of ER␣ and ER␤ mRNA expression in ovaries containing different follicular structures is shown in Fig. 3B . A subset of corpora lutea which express LH-R mRNA have been found to weakly express ER␤ mRNA (upper panel, shown are corpora lutea from metestrus 1800 h). Interestingly, small follicles expressing LH-R mRNA only in theca cells in the same field clearly expressed ER␤ mRNA in Approximately 40 g RNA from ovaries (as well as isolated granulosa cells) and uteri of immature rats (23 days of age) were separated on a 1% denaturing agarose/formaldehyde gel, the RNA was transferred to a nylon membrane, and the membrane was probed with the hormone-binding domain of the rat ER␣ cDNA (500 bp) or with the most 5Ј-end (5Ј-UTR and N-terminal A/B region) of the rat ER␤ cDNA (ϳ750 bp). Exposure was for 2 days. The same blots were subsequently reprobed to assess RNA equivalence using clone CHO-B. The ribosomal bands 28S and 18S are indicated. Panel B shows RT-PCR (66 C annealing temperature) of ER␣ and ER␤ transcripts in the ovary as a function of cycle numbers. An autoradiogram of a polyacrylamide gel on which the products of an RT-PCR assay have been separated and its quantification data are shown. The ER␣ or ER␤ PCR product is indicated as is the ribosomal protein S16 internal control. Panel C shows the specificity of our RT-PCR for ER␣ and ER␤ transcripts. ER␣ and ER␤ cDNAs were used as controls. granulosa cells. Throughout folliculogenesis in adult rats during the estrous cycle as well as in immature rats during PMSG treatment, all growing follicles, regardless of their size (small, antral, or preovulatory), were found to express ER␤ mRNA [shown are ovarian sections of PMSG-treated (10 IU, 48 h) immature rats, lower panel]; as previously shown (34), preovulatory follicles express LH-R mRNA in granulosa cell layers (34). The colocalization of LH-R mRNA and ER␤ mRNA in follicles at different stages is shown at higher magnifications in Fig. 4A . Small follicles (indicated by an arrow, left panel) with LH-R mRNA in the theca, but not granulosa, cell layer (34) clearly express ER␤ mRNA in the granulosa, but not theca, cell layer. Preovulatory follicles (also indicated by an arrow, right panel) with LH-R mRNA in both granulosa and theca cell layers (34) also express ER␤ mRNA, although at a decreased level, in the granulosa cell layer. Figure 4B shows colocalization of LH-R or PR mRNA with ER␤ mRNA in preovulatory follicles in immature rats challenged with hCG. Three hours after hCG treatment, granulosa cell expression of LH-R mRNA is persistent in preovulatory follicles. In contrast, ER␤ mRNA expression in the same follicles is markedly decreased whereas nonpreovulatory follicles (absence of LH-R mRNA in granulosa cells) persistently express ER␤ mRNA. Six hours after hCG treatment, granulosa cell expression of PR mRNA is evident in preovulatory follicles (29), which express little ER␤ mRNA. Again, nonpreovulatory follicles (absence of PR mRNA expression) persistently expressed ER␤ mRNA.
To further determine the potential role of the pituitary gonadotropins, FSH and LH, in regulating ER␤ mRNA expression in the ovary, we examined immature rats treated with PMSG followed by hCG. ER␤ mRNA expression in these rat ovaries was determined initially by RT-PCR (Fig. 5 ). PMSG treatment (up to 48 h) did not significantly alter total ovarian content of ER␤ mRNA levels. In contrast, a subsequent injection of hCG (up to 12 h) in rats similarly treated with PMSG (48 h) substantially decreased ER␤ mRNA levels. To examine the effects of PMSG and hCG on ER␤ mRNA expression at a cellular level, we performed in situ hybridization on ovaries of similarly treated rats. As shown in Fig. 6 , the granulosa cells of preantral as well as antral follicles of untreated immature rats clearly express ER␤ mRNA at a detectable level. During folliculogenesis stimulated by PMSG treatment, ER␤ mRNA expression in growing follicles appears to decrease. Forty-eight hours after PMSG treatment, the granulosa cells of preovulatory follicles clearly express LH-R mRNA as well as ER␤ mRNA. During short-term treatment with hCG (3 h), down-regulation of ER␤ mRNA is evident in the preovulatory follicles still expressing LH-receptors, suggesting that ER␤ mRNA is rapidly down-regulated; six h after hCG injection, both LH-R and ER␤ mRNA levels were reduced.
The Effect of hCG on ER␤ mRNA Expression in Cultured Rat Granulosa Cells
To examine the ability of hCG to modulate ER␤ mRNA expression by directly acting on granulosa cells cultured in vitro, we isolated differentiated granulosa cells from immature rats primed with PMSG (10 IU, 44 h) and cultured in vitro. Cells were treated with hCG (I IU/ml) for 3-12 h, and RNA was examined for ER␤ mRNA levels by RT-PCR. As shown in Fig. 7A (3-h incubation), granulosa cells contain a fairly high level of ER␤ mRNA, and incubation of these cells with hCG decreased ER␤ mRNA to 50% of the original value. Activation of LH receptor-associated signaling pathways by using activators for protein kinases A (forskolin, 10 Ϫ5 M) and C [a phorbol 12-myristate 13-acetate (TPA), 10
Ϫ7 M] results in ER␤ mRNA downregulation in cultured rat granulosa cells. Interestingly, forskolin and TPA act together to further decrease ER␤ mRNA levels in these cells. This inhibitory effect of forskolin or TPA on ER␤ mRNA levels in granulosa cells lasts at least up to 12 h as shown in Fig. 7B .
Fig. 2. Expression of the ER␣ and ER␤ Genes in the Ovary of Adult Rats during the Estrous Cycle
Upper panel shows an autoradiogram of a polyacrylamide gel on which the products of an RT-PCR assay have been separated. The ER␣ and ER␤ PCR products are indicated as is the ribosomal protein S16 internal control. Times during the estrous cycle are indicated at the top. Bottom panel shows the quantification of the data in panel A. Band intensities were measured on a PhosphoImager, and the ER␣ or ER␤ signals were normalized to the S16 internal control for each time point. Relative mRNA levels were shown as the value at E1100 being 1.0. Sera from these animals were used to determine LH concentrations; the onset of the LH surge was observed at 1600 h of proestrus, and the peak was observed at 1800 h of proestrus.
DISCUSSION Predominant Expression of ER␤ in Granulosa Cells
Estrogen-signaling events are believed to critically affect a spectrum of physiological processes by interacting with an intracellular receptor (ER), a ligandinducible transcription factor (35). Thus, the expression level of ER in a particular tissue has been used as an index of the degree of estrogen responsiveness (22, 23) . In many female reproductive tissues, ER expression levels correlate with the ability of estrogen to stimulate expression of an array of well characterized target genes such as the PR gene (22, 23, 36 ). This tight cause-effect relationship between ER and PR expression appears to be uncoupled in the ovary. Although estrogen is essential for the growth of ovarian follicles (1-7) that clearly display specific binding sites for estrogen (14) (15) (16) (17) (18) (19) , this steroid fails to directly stimulate the PR gene in ovarian follicles (30-32). In addition, the lack of expression of a full-length and functional ER␣ in ER␣ null mutant mice (27-28, 37) did not prevent the growth of follicles, which resulted in high circulating estrogen levels (28, 37), suggesting the possibility that the ovary expresses estrogen-binding molecule(s) other than ER␣. Consistent with this possibility are our results demonstrating that ER␤ is the primary ER subtype expressed in the ovary, in particular granulosa cells of small, growing, and preovulatory follicles. Thus, the ovarian responsiveness to estrogen in the ER␣ knockout mice (27, 37) may result from the expression of ER␤. Our results, however, do not exclude the potential importance of ER␣ in ovarian functions. Indeed, experimental results of ours (this report) and others (38, 39) show the evident, although low, expression of the ER␣ gene in the ovary. Coexpression of ER␣ and ER␤ in the same follicles suggests the interesting possibility that ER␣ and ER␤ proteins may interact with each other and discriminate between target sequences leading to differential responsiveness to estrogen. Because both ER␣ and ER␤ proteins bind estrogen with an affinity of ϳ10 Ϫ9 M and display the same steroid specificity (20) (21) , it is highly unlikely that differential responsiveness to estrogen is achieved at the level of interaction between ligand and receptor. Because ER␤, like ER␣, when expressed in transfected cells, has been shown to be capable of transactivating a simple artificial estrogen response element-containing promoter (21) , it is possible that differential responsiveness to estrogen may be achieved at the level of interactions between ER␣ and ER␤ or between ERs and DNA. Interestingly, PR A , the N-terminally truncated naturally occurring isoform of PR B , functions as a transactivator in some cells as a homodimer whereas it serves as a repressor of PR B when both isoforms are present (40-42). Perhaps similar mechanisms for estrogen responsiveness could be operating in cells expressing both ER␣ and ER␤. In this regard, it is interesting to note that the N-terminal domain of the ER␤ protein is not homologous to, and is much shorter than, the corresponding region of the ER␣ protein. In cells in vivo, the ratio of ER␣/ER␤ mRNA varies significantly among estrogen target tissues (Ref. 21 and our results). Our results show that the ratio of ER␤/ER␣ in the ovary is much higher than in the uterus, a well known estrogen target. In uterine cells expressing high levels of ER␣ but extremely low levels of ER␤, estrogen clearly stimulates multiple physiological processes including the synthesis of PRs (43). In addition, ER␣ knockout mice fail to initiate these physiological processes in response to estrogen (37). In contrast, in the ovary, which expresses relatively high levels of ER␤ but low levels of ER␣, total elimination of ER␣ failed to disrupt normal growth of ovarian follicles (37). In addition, estrogen failed to directly stimulate PR gene expression in normal preovulatory follicles (30-32). Although one possible explanation is that these two cell types (uterus and ovary) express different coactivators facilitating the interactions between ERs and general transcription factors; another possibility is that these two cell types respond 
. Colocalization of LH-R (or PR) and ER␤ mRNAs in Follicular Structures
Panel A shows small (left, an immature rat treated with PMSG for 48 h plus hCG for 3 h) and preovulatory (right, an immature rat treated with PMSG for 48 h) follicles expressing both LH-R mRNA and ER␤ mRNA. In each case, the follicle indicated by an arrow is shown at higher magnifications. Granulosa (G) and theca (T) cell layers are also indicated. Panel B shows colocalization of LH-receptor (or progesterone receptor) mRNA and ER␤ mRNA in serial ovarian sections of immature rats treated with PMSG (10 IU, 48 h) followed by hCG (10 IU) for 3 or 6 h. Some preovulatory follicles are indicated by arrows. The probes are indicated, and all photographs were taken at 50ϫ magnification.
to estrogen differently because of the different ratio of ER␣/ER␤ expression. It will be important to determine whether ER␣ and ER␤ proteins are coexpressed within a single cell, whether ER␣ and ER␤ could potentially dimerize with each other, and whether ER␣ and ER␤ homodimers, as well as ER␣/ER␤ heterodimers, would exhibit cell context-dependent and promoter-dependent transactivation function.
Hormonal Regulation of ER␤ mRNA Expression by Gonadotropins
In many estrogen target tissues such as the uterus and pituitary, estrogen and progesterone modulate levels of ER␣ protein as well as mRNA (22, 23, 36, 43) . In the ovary, estrogen-binding sites have been shown to be modulated by the pituitary gonadotropins (17) . The discrepancy between our RT-PCR results showing that ER␤ mRNA in whole ovary remained more or less similar during folliculogenesis (proliferation of granulosa cells) and our in situ hybridization results showing an apparent decrease in ER␤ mRNA in granulosa cells of large and preovulatory follicles may be explained by the fact that whole ovary contains an increased number of granulosa cells during folliculogenesis. This possibility is consistent with a published observation that estrogen-binding sites per granulosa cells decrease after PMSG treatment (48 h) (17) . During PMSG treatment the follicular synthesis of estrogen significantly increases and thus the PMSG-induced decrease in granulosa cell expression of ER␤ mRNA may result from PMSG-induced estrogen production and/or PMSG-induced intracellular signaling pathways. Curiously, ER␤ mRNA levels in whole ovary are substantially decreased after the onset of the gonadotropin surge in cycling rats and after hCG injection in PMSG-primed immature rats. Our in situ hybridization data showing colocalization of ER␤, LH-R, and PR mRNAs in immature rats treated with gonadotropins argue that LH/CG-induced down-regulation of ER␤ mRNA in whole ovaries is attributable, at least in part, to the loss of ER␤ mRNA in preovulatory follicles responding to LH/CG. In these experiments, only preovulatory follicles expressing LH-R mRNA lose ER␤ mRNA in response to hCG challenge. Similarly, all preovulatory follicles expressing PR mRNA in response to LH/CG (29, 30) express little ER␤ mRNA while neighboring follicles without PR mRNA (indicative of the lack of LH-R) express a normal level of ER␤ mRNA. This observation is consistent with a previous report demonstrating that hCG induces down-regulation of estrogen receptor-binding sites (17) . Our results demonstrating the ability of protein kinase A (forskolin) and protein kinase C (TPA) activators to induce this type of down-regulation of ER␤ mRNA levels in cultured granulosa cells indicate that the intracellular signals generated by the preovulatory LH surge in differentiated granulosa cells initiate the molecular cascade of events leading to either rapid degradation of ER␤ mRNA and/or transcriptional turn-off of the ER␤ gene. In MCF-7 breast cancer cells in which the ER␣ gene has been shown to be down-regulated by estrogen (44), a phorbol ester TPA has also been shown to down-regulate ER␣ mRNA expression by facilitating rapid degradation of ER␣ messages (45). It remains to be determined whether similar mechanisms perhaps mediate ER␣ degradation in nontumor cells. Although the importance of the LH-induced down-regulation of ER␤ mRNA in preovulatory follicles is currently unknown, there must be another hormonal cue that increases ER␤ mRNA expression by increasing either mRNA stability or transcriptional rate, as evident from a subset of corpora lutea of cycling rat ovaries expressing levels of ER␤ mRNA that are slightly above background. Functional corpora lutea of pregnant rats also express ER␤ mRNA (M. Byers and O-K. ParkSarge, unpublished observation). Thus, future studies will be required to determine the molecular mechanisms by which ER␤ mRNA expression is regulated in granulosa/luteal cells.
In summary, our results demonstrating that ER␤ is the primary ER subtype expressed in the ovary, that ER␤ is expressed in granulosa cells of virtually all healthy follicles, and that ER␤ is down-regulated by gonadotropins in granulosa cells suggests the possibility that in the ovary, the functional significance of estrogen action may be mediated primarily by ER␤.
Fig. 5. Modulation of Ovarian ER␤ mRNA Expression by Gonadotropins in Immature Rats
Upper panel shows an autoradiogram of a polyacrylamide gel on which the products of an RT-PCR assay have been separated while lower panel shows the quantification of the data. Band intensities were measured on a PhosphoImager, and the ER␤ signal was normalized to the S16 internal control for each experimental group. The ratio of ER␤/S16 of control rats with no hormonal treatment was considered 1.0. Shown are the mean Ϯ SE (n ϭ 4).
MATERIALS AND METHODS
Animals and Hormone Treatments
Two sets of animals were used for these studies: immature female rats treated with gonadotropins and sexually mature adult female rats exhibiting regular 4-day estrous cycles. All animals are treated according to the NIH guidelines for the care and use of animals. Immature Animals.
Sprague-Dawley female pups (21 days old) with a nursing mother were purchased from Harlan Breeding Company (Indianapolis, IN) and housed in a photoperiod of 14-h light, 10-h darkness, with lights on at 0500 h. Food and water were freely available. At 23 days of age, rats were injected s.c. with 10 IU PMSG (Sigma, St Louis MO) in 0.1 ml PBS. Forty-eight hours later, rats were injected s.c. with 10 IU hCG (Sigma) in 0.1 ml PBS. Rats were killed by decapitation at various time points throughout hormone treatments, and their ovaries were rapidly removed from surrounding fat and oviduct, frozen on dry ice and stored until use at Ϫ80 C. Sexually Mature Adult Rats. Adult female Sprague-Dawley rats (150-180 g body weight) were purchased from CharlesRivers Breeding Company (Wilmington, MA) and were housed as above. Estrous cyclic stages were determined by daily examination of vaginal cytology, and only those animals demonstrating at least two consecutive 4-day cycles were used for the experiment. Rats were euthanized at specific time intervals throughout the estrous cycle. Trunk blood was collected for serum LH measurements, and ovaries were rapidly removed from surrounding fat and oviduct, frozen on dry ice, and stored until use at Ϫ80 C. Serum LH concentrations in these cycling rats were determined by an RIA using the NIH NIDDK kit with the exception of LH antibody CSU 120, which was generously provided by Dr. Terry Nett.
Granulosa Cell Isolation and Culture
Immature rats at 22-23 days of age were primed with a single s.c. injection of PMSG (10 IU) and 40-44 h later, granulosa cells were isolated by the method of follicular puncture (30, 46, 47). Ovaries were collected in cold serum-free medium (4F) consisting of 15 mM HEPES (pH 7.4), 50% Dulbecco's MEM and 50% Ham's F12 with bovine transferrin (5 g/ml), human insulin (2 g/ml), hydrocortisone (40 ng/ml), and antibiotics. After incubation in warm (37 C) 4F medium containing 0.5 M sucrose and 10 mM EGTA for 20-30 min to loosen cell junctions, ovaries were washed in fresh 4F medium, and individual follicles were punctured using 23-gauge needles. Extruded granulosa cells were collected, washed twice, and plated in 4F medium supplemented with 5% FBS (GIBCO, Grand Island, NY) at a density of approximately 2 ϫ 10 6 cells per 100-mm dish, incubated overnight in the humidified atmosphere of 5% CO 2 at 37C, and treated with various hormones.
RNA Blot Analysis
Total RNA was prepared from ovaries at the indicated time points by homogenization in guanidine isothiocynate and centrifugation through cesium chloride (48, 49). Approximately 40 g of each was separated by electrophoresis on denaturing 1% agarose/formaldehyde gels. RNA was transferred to a nylon membrane (Schleicher & Schuell, Keene, NH), baked in a vacuum oven at 80 C for 2 h, and hybridized at 42 C with 32 P-dCTP-labeled ER␣ [the ϳ500-bp hormonebinding domain (20) ] or ER␤ [the ϳ200-bp 5Ј-untranslated region (UTR) and A/B region (21)]-specific probe in 50% formamide, 5 ϫ SSPE (750 mM NaCl, 50 mM NaH 2 PO 4 , pH 7.4, 1 mM EDTA), 2 ϫ Denhardt's reagent, 10% dextran sulfate, 0.1% SDS, and 100 g/ml salmon sperm DNA. The membranes were subsequently washed in 0.1 ϫ NaCl-sodium citrate (SSC) at 65 C and exposed to Kodak XAR-5 film (Eastman Kodak, Rochester, NY). After removal of probe in 50% formamide at 65 C, the membranes were rehybridized to cDNA clone CHO-B (50), which detects the LLRep3 gene family (51), to assess the amount of RNA present in each lane.
In Situ Hybridization
Ovaries were removed from storage at Ϫ80 C and brought to Ϫ20 C, and 20-m sections were cut using a Zeiss cryostat. Sections were mounted onto positively charged glass slides, (21), a PCR clone encoding the hormone-binding domain of the rat ER␣ cDNA (20) , the rat LH-R PCR clone (34), and the rat PR PCR clone (29). The RNA probe (2 ϫ 10 7 cpm/ml in hybridization buffer: 50% formamide, 5 ϫ SSPE (750 mM NaCl, 50 mM NaH 2 PO 4 , pH 7.4, 1 mM EDTA), 2 ϫ Denhardt's reagent, 10% dextran sulfate, 0.1% SDS, and 100 mg/ml yeast tRNA) was applied to the tissue sections, and the sections were overlaid with a coverslip. Slides were hybridized in a humidity chamber at 47 C for 16-18 h. After hybridization, the coverslips were removed and sections were treated with RNase A (20 g/ml) at 37 C for 30 min, washed in increasingly lower concentrations of SSC down to 0.1 ϫ SSC at 55 C, and dehydrated through an ethanol series. The slides were exposed to Kodak XAR-5 film for 2-3 days at room temperature and were then processed for liquid emulsion autoradiography using NTB-2 emulsion (Kodak). Slides were developed using Kodak D-19 developer and fixer and stained with hematoxylin.
RT-PCR Analysis
Oligonucleotide primer pairs of 20-22 nucleotides (40-60% GC content) were designed based on the sequences of the (20)], and rat ribosomal protein S16 [amplifying nucleotides from 59 to 109 (52)]. The predicted sizes of the amplified products are 203 bp (ER␤), 115 or 400 bp depending on the primer sets (ER␣), and 100 bp (S16). The conditions were such that amplification of the product was linear with respect to the amount of input RNA. Five micrograms of total RNA were reverse-transcribed at 37 C using random hexamer primers and MMLV reverse transcriptase (New England Biolabs, Boston, MA) in a 20-l reaction. Five microliters of the cDNA samples were used for the subsequent PCR amplification of ER␣, ER␤, and S16 cDNAs. A 20 l mix including the oligonucleotide primers (50 ng each), ␣-32 P-dCTP (2 Ci at 3000 Ci/mmol), and Taq DNA polymerase (2.5 U) in 1 ϫ PCR buffer (10 mM Tris, pH 8.3, 50 mM KCl, 1.5 mM MgCl 2 , 0.01% gelatin) was added to each cDNA sample and overlaid with light mineral oil. Amplification was carried out for 25 cycles using an annealing temperature of 65 C on a Perkin Elmer Cetus thermalcycler (Perkin Elmer Cetus, Norwalk, CT). The samples were then electrophoresed on a 8% polyacrylamide gel. After autoradiography, the gel was analyzed using a Molecular Dynamics PhosphoImager and ImageQuant version 3 software (Molecular Dynamics, Sunnyvale, CA). The intensity of the ER␣ and ER␤ signal was normalized to that of the ribosomal protein S16 internal control. 
